Medical Device Network on MSN
Minze Health and Medtronic agree on three-year partnership for bladder care
As part of the collaboration, Minze Diary Pod will be incorporated into the sacral neuromodulation care pathway.
Minze Health NV signed a three-year agreement with Medtronic plc to bring its Minze Diary Pod, an app-controlled automated ...
Minze Health announced that it entered into a three-year agreement with Medtronic to commercialize its overactive bladder ...
Hosted on MSN
Understanding bladder cancer risk and treatment
Social Security, Medicare are "going to be gone," Donald Trump warns Shohei Ohtani Airplane Joke Is Going Viral Ahead of Dodgers-Blue Jays World Series Nickels only? Grocers warn ending pennies could ...
NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...
Red light masks and wands are all the rage, and this GLO24K one is on sale right now for October Prime Day. Right now, you can secure this GLO24K Red Light for Face & Neck Beauty Device for just $65, ...
Individuals with lupus may be at a higher risk of developing interstitial cystitis, a chronic condition characterized by inflammation, pain, and pressure in the bladder. Interstitial cystitis, also ...
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new phase III randomized trial.
Medtronic has received Food and Drug Administration approval for a neuromodulation therapy in urge urinary incontinence, the company said Friday. The Altaviva device is inserted near the ankle and ...
Credit: Thinkstock Investigators conducted a network meta-analysis of phase 3 trials on MIBC treatments to provide comparative ranking of perioperative therapies. Findings from studies over 30 years ...
COLUMBIA, S.C. (WIS) - Urinary incontinence is a condition many people live with, but few are comfortable talking about. It affects both men and women, often disrupting daily life in ways that can ...
After implantation, patients are able to return home with the therapy activated; no daily interventions or manual adjustments are required. The Food and Drug Administration (FDA) has cleared Medtronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results